KVP Capital Advisors »

Arrivent Biopharma shares owned by KVP Capital Advisors

Quarter-by-quarter ownership of Arrivent Biopharma (AVBP) shares owned by KVP Capital Advisors from 13F filings

Historical chart of KVP Capital Advisors investment in Arrivent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arrivent Biopharma held by KVP Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrivent Biopharma by KVP Capital Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.5M 102k 34.74

More positions owned by KVP Capital Advisors

Praxis Precision Medicines I Com New (PRAX)
Aadi Bioscience (WHWK)
Erasca (ERAS)
Trevi Therapeutics (TRVI)
Sutro Biopharma Com Shs (STRO)
Tango Therapeutics (TNGX)
Mbx Biosciences (MBX)
Protagonist Therapeutics (PTGX)
Edgewise Therapeutics (EWTX)
Tandem Diabetes Care Com New (TNDM)
Disc Medicine (IRON)
Savara (SVRA)
Arrivent Biopharma (AVBP)
Insmed Com Par $.01 (INSM)
Achieve Life Sciences (ACHV)

View all positions for KVP Capital Advisors

Top funds holding Arrivent Biopharma

Suvretta Capital Management
Infinitum Asset Management
Hillhouse Capital Advisors
BlackRock
OrbiMed Advisors
FMR
Octagon Capital Advisors
Vanguard Capital Management
Sofinnova Ventures
Vivo Capital
Novo A/S
General Catalyst Group Management
State Street Corporation
Logos Global Management
Geode Capital Management

View all funds holding Arrivent Biopharma